Dialysis Clinic Inc is a 501(c)(3) organization based in Nashville, Tennessee, registered in 1972, with $736,387,532 in FY2023 revenue. CharityIndex grades it B+, and it directs about 68% of spending to programs.
Revenue (FY2023)
$736.4M
▲ 1.1% vs prior year
Health median: $840K
Expenses (FY2023)
$720.2M
Net assets
$523.8M
Employees
6,255
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Dialysis Clinic Inc: 68% to programs · $0 to raise $100 earns a B on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Dialysis Clinic Inc: 9 mo reserves · +2% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Dialysis Clinic Inc: 4 of 6 checks met earns a B on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Dialysis Clinic Inc: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
To provide comprehensive and specialized care to patients living with chronic kidney disease (ckd) and end stage renal disease (esrd).
The lab division provides specialized laboratory testing and diagnostic procedures for dialysis facilities and patients with kidney disease and renal failure. a variety of laboratory tests to analyze diffused toxins from the blood are necessary to monitor the clinical course of patients and the overall effectiveness of renal dialysis. these tests are necessary in the treatment of renal disease, and furthers our exempt purpose of providing quality care for patients with chronic renal disease by continually improving our processes in measuring levels of kidney function to produce optimal patient outcomes. for fye 2024, 775,068 patient tests were performed.
The supply and pharmacy division provides medical supplies, including but not limited to nutritional supplements, drugs, and home dialysis supplies for dci facilities and provides prescription medications for dci employees.
Revenue grew from $604.3M (FY2013) to $736.4M (FY2023) across 11 reported years.
Financial snapshot
Operating margin
2.2%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$697.7M
Total liabilities
$173.9M
Net assets
$523.8M
Salaries & benefits
$427.4M
59% of expenses
Board members
4
0 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $736,387,532▲1.1% | $720,249,084▼3.3% | $523,833,006▲1.2% | $697,727,403▲0.3% | 990 |
| 2022 | $728,068,130 | $744,815,158▼12.2% | $517,572,597▼2.6% | $695,959,374▲7.1% | 990 |
| 2021 | $727,825,569▼3.4% | $848,633,522▲13.8% | $531,302,425▼18.2% | $649,708,855▼18.4% | 990 |
| 2020 | $753,633,577▼1.6% | $745,611,982▲0.1% | $649,271,478▲1.7% | $795,817,725▲1.6% | 990 |
| 2019 | $765,633,140▲3.6% | $744,985,667▲1.9% | $638,121,784▲4.1% | $782,995,317▲9.7% | 990 |
| 2018 | $739,130,845▲4.9% | $731,344,904▲4.0% | $612,817,876▲1.7% | $714,063,423▲0.8% | 990 |
| 2017 | $704,855,490▲3.8% | $702,895,895▲6.2% | $602,387,123▲0.4% | $708,661,934▲1.8% | 990 |
| 2016 | $679,222,021▲7.2% | $661,733,710▲9.9% | $599,809,006▲3.0% | $695,873,962▲2.6% | 990 |
| 2015 | $633,357,748▼2.2% | $602,049,483▼3.0% | $582,367,748▲5.6% | $678,136,236▲3.9% | 990 |
| 2014 | $647,725,309▲7.2% | $620,403,641▲7.9% | $551,581,258▲5.4% | $652,776,917▲5.4% | 990 |
| 2013 | $604,333,631 | $574,781,552▲2.5% | $523,191,515▲6.1% | $619,435,363▲5.8% | 990 |
| 2012 | — | $560,879,736▲2.7% | $492,905,336▲9.6% | $585,226,085▲7.8% | 990 |
| 2011 | — | $545,883,613▲4.0% | $449,820,321▲10.0% | $542,792,456▲10.4% | 990 |
| 2010 | — | $524,822,287▼6.6% | $408,878,639▲12.4% | $491,506,006▲8.3% | 990 |
| 2009 | — | $562,058,537 | $363,735,068 | $453,879,589 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Amit Nahata — $691,509 (0.10% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Amit Nahata | Physician | 40 | $691,509 |
| Joseph Dejonckheere | Physician | 40 | $585,292 |
| Raphael Higginbotham | Physician | 40 | $520,934 |
| Ayman Geneidy | Physician | 40 | $477,474 |
| Donovan Schultz | President | 38 | $468,242 |
| Mostafa Amr | Physician | 40 | $460,624 |
| Stuart Redpath | Chief Operating Officer | 40 | $447,199 |
| Douglas Johnson Md | Vice Chairman | 39 | $445,892 |
| William Wood | Former President | 0 | $417,734 |
| Mary Hobeika | Chief Strategy Officer | 40 | $310,350 |
| Joe Swearingen | Chief Financial Officer | 39 | $271,319 |
| James E Attrill | Vice President | 15 | $61,787 |
| H Keith Johnson Md | Chairman of the Board | 32 | $11,684 |
| James Perry | Director | 9 | — |
| Ken Johnson | Director | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| Medical Solutions LLC | Medical Staffing | $12,376,818 |
| Invicta Construction Solutions Inc | Construction | $7,657,693 |
| Aon Consulting Inc | Benefits Consulting | $3,922,083 |
| Ups | Shipping Services | $2,722,403 |
| Quik Travel Staffing Inc | Medical Staffing | $2,384,170 |
17 grants totaling $6.9M in FY2023 — showing the 15 largest. All grants made by Dialysis Clinic Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| American Kidney Fund Inc | Donation for general support | $4,000,000 |
| University of New Mexico Foundation Incorporated | Medical research related to kidney function | $621,363 |
| Mass General Brigham Incorporated | Medical research related to kidney function | $370,000 |
| Uc Health Foundation | Medical research related to kidney function | $352,035 |
| University of Arkansas | Medical research related to kidney function | $273,974 |
| Indiana University | Medical research related to kidney function | $262,931 |
| University of Missouri | Medical research related to kidney function | $250,000 |
| Rutgers University Foundation | Medical research related to kidney function | $225,944 |
| Stony Brook Foundation Inc | Medical research related to kidney function | $142,241 |
| Tufts Medical Center Physicians Organization Inc | Medical research related to kidney function | $65,436 |
| Vanderbilt University Medical Center | Medical research related to kidney function | $60,000 |
| Kidney Foundation of the Greater Chattanooga Area Inc | Donation for general support | $60,000 |
| University of Connecticut Health Center | Medical research related to kidney function | $53,500 |
| Research Foundation For the State University of New York | Medical research related to kidney function | $46,669 |
| The Medical University of South Carolina Foundation | Medical research related to kidney function | $30,000 |
Explore more
Data for Dialysis Clinic Inc (EIN 62-0850498) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.